MedTrace Logo

The Comparison of Different Administration Routes of Pediatric Premedication

NCT02313337 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-12-10

No results posted yet for this study

Summary

The study purpose is to compare the effect of different Administration Routes of Pediatric Premedication (including oral administration, intramuscular injection, rectal perfusion, intranasal).

Conditions

  • Anesthesia

Interventions

OTHER

Oral administration

Premedicate--Oral administration of a mixture at preoperative 30 minutes: ketamine 3 mg/kg, midazolam 0.5 mg/kg and atropine 0.02 mg/kg, plus 50% glucose solution to 0.5ml /kg.

OTHER

Intramuscular injection

Premedicate--At preoperative 30 minutes intramuscular injection of atropine 0.02 mg/kg, 5 minutes before entering the operation room, intramuscular injection of ketamine 5 mg/kg.

OTHER

Rectal perfusion

Premedicate--At preoperative 30 minutes rectal infusion of midazolam 0.5mg/kg

OTHER

Dripping nose

Premedicate--At preoperative 30 minutes dripping nose of Imidazole valium 0.2 mg/kg

DRUG

Anesthesia induction(midazolam,fentanyl,propofol,atracurium)

After entering the operation room ,all cases intravenous midazolam 0.05 mg/kg, fentanyl 3μg/kg, closed-loop target controlled infusion propofol and atracurium .

PROCEDURE

Intubation

Intubation when the trachea-oesophageal fistula（TOF） value fell 15%, BIS value dropped to 40.

DRUG

Anesthesia maintenance(midazolam,fentanyl,propofol,atracurium)

All cases intravenous midazolam 0.05 mg/kg, fentanyl 3μg/kg, closed-loop target controlled infusion propofol and atracurium .

Sponsors & Collaborators

  • Second Affiliated Hospital of Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • NIU XIAOLI · The second affiliated hospital of xi 'an jiaotong university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313337 on ClinicalTrials.gov